The Biogen Inc., headquarters, Wednesday, March 11, 2020, in Cambridge, Mass. (AP Photo/Steven Senne)
Matthew Perrone and Tom Murphy Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer’s drug Aduhelm less than a year after…
